These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37713444)

  • 1. Saturation genome editing of 11 codons and exon 13 of BRCA2 coupled with chemotherapeutic drug response accurately determines pathogenicity of variants.
    Sahu S; Sullivan TL; Mitrophanov AY; Galloux M; Nousome D; Southon E; Caylor D; Mishra AP; Evans CN; Clapp ME; Burkett S; Malys T; Chari R; Biswas K; Sharan SK
    PLoS Genet; 2023 Sep; 19(9):e1010940. PubMed ID: 37713444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saturation genome editing-based functional evaluation and clinical classification of BRCA2 single nucleotide variants.
    Huang H; Hu C; Na J; Hart SN; Gnanaolivu RD; Abozaid M; Rao T; Tecleab YA; Pesaran T; Lyra PCM; Karam R; Yadav S; Domchek SM; de la Hoya M; Robson M; Mehine M; Bandlamudi C; Mandelker D; Monteiro ANA; Boddicker N; Chen W; Richardson ME; Couch FJ
    bioRxiv; 2023 Dec; ():. PubMed ID: 38168194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional pre-therapeutic evaluation by genome editing of variants of uncertain significance of essential tumor suppressor genes.
    Billaud A; Chevalier LM; Augereau P; Frenel JS; Passot C; Campone M; Morel A
    Genome Med; 2021 Nov; 13(1):174. PubMed ID: 34749799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots".
    Dines JN; Shirts BH; Slavin TP; Walsh T; King MC; Fowler DM; Pritchard CC
    Genet Med; 2020 May; 22(5):825-830. PubMed ID: 31911673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs.
    Biswas K; Mitrophanov AY; Sahu S; Sullivan T; Southon E; Nousome D; Reid S; Narula S; Smolen J; Sengupta T; Riedel-Topper M; Kapoor M; Babbar A; Stauffer S; Cleveland L; Tandon M; Malys T; Sharan SK
    Cell Rep Methods; 2023 Nov; 3(11):100628. PubMed ID: 37922907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment.
    Toland AE; Andreassen PR
    J Med Genet; 2017 Nov; 54(11):721-731. PubMed ID: 28866612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
    Ricks-Santi L; McDonald JT; Gold B; Dean M; Thompson N; Abbas M; Wilson B; Kanaan Y; Naab TJ; Dunston G
    Ethn Dis; 2017; 27(2):169-178. PubMed ID: 28439188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
    Kim JH; Park S; Park HS; Park JS; Lee ST; Kim SW; Lee JW; Lee MH; Park SK; Noh WC; Choi DH; Han W; Jung SH
    Sci Rep; 2021 Apr; 11(1):8485. PubMed ID: 33875706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and ES cell-based functional evaluation of BRCA2 variants identified in families with breast cancer.
    Sullivan T; Thirthagiri E; Chong CE; Stauffer S; Reid S; Southon E; Hassan T; Ravichandran A; Wijaya E; Lim J; Taib NAM; Fadzli F; Yip CH; Hartman M; Li J; van Dam RM; North SL; Das R; Easton DF; Biswas K; Teo SH; Sharan SK; ;
    Hum Mutat; 2021 Feb; 42(2):200-212. PubMed ID: 33314489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reclassification of
    Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
    J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Categorization of
    Bouwman P; van der Heijden I; van der Gulden H; de Bruijn R; Braspenning ME; Moghadasi S; Wessels LFA; ; Vreeswijk MPG; Jonkers J
    Clin Cancer Res; 2020 Sep; 26(17):4559-4568. PubMed ID: 32546644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models.
    Hart SN; Hoskin T; Shimelis H; Moore RM; Feng B; Thomas A; Lindor NM; Polley EC; Goldgar DE; Iversen E; Monteiro ANA; Suman VJ; Couch FJ
    Genet Med; 2019 Jan; 21(1):71-80. PubMed ID: 29884841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
    Liu Y; Wang H; Wang X; Liu J; Li J; Wang X; Zhang Y; Bai Z; Zhou Q; Wu Y; Shen Y; Weng X; Liu F; Guo J; Di L; Gires O; Zhang Z; Chen Y; Wang H
    J Hematol Oncol; 2021 Jan; 14(1):18. PubMed ID: 33461583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRCA1 and BRCA2 unclassified variants and missense polymorphisms in Algerian breast/ovarian cancer families.
    Cherbal F; Salhi N; Bakour R; Adane S; Boualga K; Maillet P
    Dis Markers; 2012; 32(6):343-53. PubMed ID: 22684231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional classification of DNA variants by hybrid minigenes: Identification of 30 spliceogenic variants of BRCA2 exons 17 and 18.
    Fraile-Bethencourt E; Díez-Gómez B; Velásquez-Zapata V; Acedo A; Sanz DJ; Velasco EA
    PLoS Genet; 2017 Mar; 13(3):e1006691. PubMed ID: 28339459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay.
    Sirisena N; Biswas K; Sullivan T; Stauffer S; Cleveland L; Southon E; Dissanayake VHW; Sharan SK
    Breast Cancer Res; 2020 May; 22(1):43. PubMed ID: 32393398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of BRCA2 R3052Q variant in mice supports its functional impact as a low-risk variant.
    Mishra AP; Hartford S; Chittela RK; Sahu S; Kharat SS; Alvaro-Aranda L; Contreras-Perez A; Sullivan T; Martin BK; Albaugh M; Southon E; Burkett S; Karim B; Carreira A; Tessarollo L; Sharan SK
    Cell Death Dis; 2023 Nov; 14(11):753. PubMed ID: 37980415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
    Wan Q; Hu L; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xu Y; Xie Y
    Fam Cancer; 2021 Apr; 20(2):85-95. PubMed ID: 32803532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional evaluation of BRCA2 variants mapping to the PALB2-binding and C-terminal DNA-binding domains using a mouse ES cell-based assay.
    Biswas K; Das R; Eggington JM; Qiao H; North SL; Stauffer S; Burkett SS; Martin BK; Southon E; Sizemore SC; Pruss D; Bowles KR; Roa BB; Hunter N; Tessarollo L; Wenstrup RJ; Byrd RA; Sharan SK
    Hum Mol Genet; 2012 Sep; 21(18):3993-4006. PubMed ID: 22678057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput functional evaluation of BRCA2 variants of unknown significance.
    Ikegami M; Kohsaka S; Ueno T; Momozawa Y; Inoue S; Tamura K; Shimomura A; Hosoya N; Kobayashi H; Tanaka S; Mano H
    Nat Commun; 2020 May; 11(1):2573. PubMed ID: 32444794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.